Loading organizations...
Loading organizations...
Biotechnology company developing small molecule RNA-targeted therapeutics.
Ribopeutic has raised $13.9M across 1 funding round.
Ribopeutic has raised $13.9M in total across 1 funding round.
Ribopeutic has raised $13.9M in total across 1 funding round.
Ribopeutic's investors include Panlin Capital, Tasly Pharmaceutical.
Ribopeutic has raised $13.9M across 1 funding round. Most recently, it raised $13.9M Pre-Series A in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 14, 2025 | $13.9M Pre-Series A | Panlin Capital, Tasly Pharmaceutical |